News

Hemianopic and quadrantanopic people have been declared safe to drive because they make more head movements into their blind field to compensate, according to a recent study published in Investigative Ophthalmology and Visual Science.

Fight for Sight, a charity funding the research for the treatment of blindness and eye disease, has contributed grants totalling £697 350 to 7 recipients

A Biologics License Application (BLA) for VEGF Trap-Eye treatment of neovascular age-related AMD has been submitted to the US Food and Drug Administration (FDA) by Regeneron Pharmaceuticals.

Oral resveratrol SRT501 significantly lowers neuronal damage, in a model of multiple scelrosis (MS).

UK firm UltraVision CLPL has agreed on a global licensing agreement with Bausch + Lomb for the marketing and sales of KeraSoft contact lens.

An investigational femtosecond laser-assisted cataract surgery system for capsulotomy creation was evaluated in a randomized, fellow eye control study.

Combined genomic and proteomic biomarkers are seemingly the most effective method for predicting progression.

A report on the status of the 5-year-old ongoing MacTel Project, which is slowly answering questions surrounding the disease.

Dr Y. Ralph Chu explains how the ongoing development of increasingly customized IOLs is providing refractive-cataract surgery patients individualized options.

Femtosecond lasers

Dr Mark Wevill discusses the changes occuring in the field of femtosecond lasers and the advantages this technology has enabled.

There are still many challenges facing clinicians in the regeneration of the optic nerve. Dr M. Francesca Cordeiro reveals encouraging research results to help overcome these barriers.